Knockdown of TFPI-2 promotes migration and invasion of glioma cells

Neuroscience Letters

Volumn 497, Issue 1, 2011, Pages 49-54

  Gessler, Florian ^a   Voss, Valerie ^a   Seifert, Volker ^a   Gerlach, Rüdiger ^a   Kögel, Donat ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Brain tumor; Cell proliferation; ECM degradation; MMPs; Tumor microenvironment; Tumor suppressor

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; PLACENTA PROTEIN 5; RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR;

ARTICLE; CANCER INVASION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; LENTIVIRINAE; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE KNOCKDOWN TECHNIQUES; GENES, TUMOR SUPPRESSOR; GLIOMA; GLYCOPROTEINS; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79956003228     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.04.027     Document Type: Article

References (27)

1. Bauer W.R., Hayes J.J., White J.H., Wolffe A.P. Nucleosome structural changes due to acetylation. Journal of Molecular Biology 1994, 236:685-690.
2. Cameron E.E., Bachman K.E., Myohanen S., Herman J.G., Baylin S.B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nature Genetics 1999, 21:103-107.
3. De Clerck Y.A., Shimada H., Gonzalez-Gomez I., Raffel C. Tumoral invasion in the central nervous system. Journal of Neuro-oncology 1994, 18:111-121.
4. Du X., Chand H.S., Kisiel W. Human tissue factor pathway inhibitor-2 does not bind or inhibit activated matrix metalloproteinase-1. Biochimica et Biophysica Acta 2003, 1621:242-245.
5. George J., Gondi C.S., Dinh D.H., Gujrati M., Rao J.S. Restoration of tissue factor pathway inhibitor-2 in a human glioblastoma cell line triggers caspase-mediated pathway and apoptosis. Clinical Cancer Research 2007, 13:3507-3517.
6. Gessler F., Voss V., Dutzmann S., Seifert V., Gerlach R., Kogel D. Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells. Neuroscience 2010, 165:1312-1322.
7. Giese A., Westphal M. Glioma invasion in the central nervous system. Neurosurgery 1996, 39:235-250. discussion 250-232.
8. Herman M.P., Sukhova G.K., Kisiel W., Foster D., Kehry M.R., Libby P., Schonbeck U. Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. The Journal of Clinical Investigation 2001, 107:1117-1126.
9. Iino M., Foster D.C., Kisiel W. Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2. Arteriosclerosis, Thrombosis, and Vascular Biology 1998, 18:40-46.
10. Iochmann S., Blechet C., Chabot V., Saulnier A., Amini A., Gaud G., Gruel Y., Reverdiau P. Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion. Clinical & Experimental Metastasis 2009, 26:457-467.
11. Konduri S.D., Osman F.A., Rao C.N., Srinivas H., Yanamandra N., Tasiou A., Dinh D.H., Olivero W.C., Gujrati M., Foster D.C., Kisiel W., Kouraklis G., Rao J.S. Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas. Oncogene 2002, 21:921-928.
12. Konduri S.D., Rao C.N., Chandrasekar N., Tasiou A., Mohanam S., Kin Y., Lakka S.S., Dinh D., Olivero W.C., Gujrati M., Foster D.C., Kisiel W., Rao J.S. A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion. Oncogene 2001, 20:6938-6945.
13. Konduri S.D., Srivenugopal K.S., Yanamandra N., Dinh D.H., Olivero W.C., Gujrati M., Foster D.C., Kisiel W., Ali-Osman F., Kondraganti S., Lakka S.S., Rao J.S. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells. Oncogene 2003, 22:4509-4516.
14. Lakka S.S., Konduri S.D., Mohanam S., Nicolson G.L., Rao J.S. In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2. Clinical & Experimental Metastasis 2000, 18:239-244.
15. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., Scheithauer B.W., Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathologica 2007, 114:97-109.
16. Miyagi Y., Koshikawa N., Yasumitsu H., Miyagi E., Hirahara F., Aoki I., Misugi K., Umeda M., Miyazaki K. cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2. Journal of Biochemistry 1994, 116:939-942.
17. Nan X., Campoy F.J., Bird A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 1997, 88:471-481.
18. Park J.B., Kwak H.J., Lee S.H. Role of hyaluronan in glioma invasion. Cell Adhesion & Migration 2008, 2:202-207.
19. Park M.J., Kim M.S., Park I.C., Kang H.S., Yoo H., Park S.H., Rhee C.H., Hong S.I., Lee S.H. PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. Cancer Research 2002, 62:6318-6322.
20. Rao C.N., Cook B., Liu Y., Chilukuri K., Stack M.S., Foster D.C., Kisiel W., Woodley D.T. HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33kDa MSPI. International Journal of Cancer 1998, 76:749-756.
21. Rao C.N., Lakka S.S., Kin Y., Konduri S.D., Fuller G.N., Mohanam S., Rao J.S. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas. Clinical Cancer Research 2001, 7:570-576.
22. Rao J.S., Steck P.A., Mohanam S., Stetler-Stevenson W.G., Liotta L.A., Sawaya R. Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. Cancer Research 1993, 53:2208-2211.
23. Senft C., Priester M., Polacin M., Schroder K., Seifert V., Kogel D., Weissenberger J. Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells. Journal of Neuro-oncology 2011, 101:393-403.
24. Tasiou A., Konduri S.D., Yanamandra N., Dinh D.H., Olivero W.C., Gujrati M., Obeyesekere M., Rao J.S. A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas. International Journal of Oncology 2001, 19:591-597.
25. Uhm J.H., Dooley N.P., Villemure J.G., Yong V.W. Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C. Clinical & Experimental Metastasis 1996, 14:421-433.
26. Wojtukiewicz M.Z., Sierko E., Zimnoch L., Kozlowski L., Kisiel W. Immunohistochemical localization of tissue factor pathway inhibitor-2 in human tumor tissue. Thrombosis and Haemostasis 2003, 90:140-146.
27. Yanamandra N., Kondraganti S., Gondi C.S., Gujrati M., Olivero W.C., Dinh D.H., Rao J.S. Recombinant adeno-associated virus (rAAV) expressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line. International Journal of Cancer 2005, 115:998-1005.